Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab
黏附、迁移和激活分子的表达调控可能预测接受伊布替尼联合利妥昔单抗治疗的慢性淋巴细胞白血病患者的疗效。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2020.262071
Peragine, Nadia; De Propris, Maria Stefania; Intoppa, Stefania; Milani, Maria Laura; Mariglia, Paola; Mauro, Francesca Romana; Raponi, Sara; Soddu, Stefano; Cuneo, Antonio; Rigolin, Gian Matteo; Del Giudice, Ilaria; Foà, Robin; Guarini, Anna
